CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids

Delilah Hendriks; Hans Clevers; Benedetta Artegiani

doi:10.1016/j.stem.2020.10.014

CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids

Delilah Hendriks, Hans Clevers, Benedetta Artegiani

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel recenseren › peer review

124 Citaten (Scopus)

Samenvatting

CRISPR-Cas technology has revolutionized biological research and holds great therapeutic potential. Here, we review CRISPR-Cas systems and their latest developments with an emphasis on application to human cells. We also discuss how different CRISPR-based strategies can be used to accomplish a particular genome engineering goal. We then review how different CRISPR tools have been used in genome engineering of human stem cells in vitro, covering both the pluripotent (iPSC/ESC) and somatic adult stem cell fields and, in particular, 3D organoid cultures. Finally, we discuss the progress and challenges associated with CRISPR-based genome editing of human stem cells for therapeutic use.

Originele taal-2	Engels
Pagina's (van-tot)	705-731
Aantal pagina's	27
Tijdschrift	Cell stem cell
Volume	27
Nummer van het tijdschrift	5
DOI's	https://doi.org/10.1016/j.stem.2020.10.014
Status	Gepubliceerd - 5 nov. 2020

Toegang tot document

10.1016/j.stem.2020.10.014

Citeer dit

@article{00bd633740ba4173a195b1f29fb10e4c,

title = "CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids",

abstract = "CRISPR-Cas technology has revolutionized biological research and holds great therapeutic potential. Here, we review CRISPR-Cas systems and their latest developments with an emphasis on application to human cells. We also discuss how different CRISPR-based strategies can be used to accomplish a particular genome engineering goal. We then review how different CRISPR tools have been used in genome engineering of human stem cells in vitro, covering both the pluripotent (iPSC/ESC) and somatic adult stem cell fields and, in particular, 3D organoid cultures. Finally, we discuss the progress and challenges associated with CRISPR-based genome editing of human stem cells for therapeutic use.",

keywords = "CRISPR-Cas Systems/genetics, Clustered Regularly Interspaced Short Palindromic Repeats/genetics, Gene Editing, Genetic Engineering, Humans, Organoids",

author = "Delilah Hendriks and Hans Clevers and Benedetta Artegiani",

year = "2020",

month = nov,

day = "5",

doi = "10.1016/j.stem.2020.10.014",

language = "English",

volume = "27",

pages = "705--731",

journal = "Cell stem cell",

issn = "1875-9777",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids

AU - Hendriks, Delilah

AU - Clevers, Hans

AU - Artegiani, Benedetta

PY - 2020/11/5

Y1 - 2020/11/5

N2 - CRISPR-Cas technology has revolutionized biological research and holds great therapeutic potential. Here, we review CRISPR-Cas systems and their latest developments with an emphasis on application to human cells. We also discuss how different CRISPR-based strategies can be used to accomplish a particular genome engineering goal. We then review how different CRISPR tools have been used in genome engineering of human stem cells in vitro, covering both the pluripotent (iPSC/ESC) and somatic adult stem cell fields and, in particular, 3D organoid cultures. Finally, we discuss the progress and challenges associated with CRISPR-based genome editing of human stem cells for therapeutic use.

AB - CRISPR-Cas technology has revolutionized biological research and holds great therapeutic potential. Here, we review CRISPR-Cas systems and their latest developments with an emphasis on application to human cells. We also discuss how different CRISPR-based strategies can be used to accomplish a particular genome engineering goal. We then review how different CRISPR tools have been used in genome engineering of human stem cells in vitro, covering both the pluripotent (iPSC/ESC) and somatic adult stem cell fields and, in particular, 3D organoid cultures. Finally, we discuss the progress and challenges associated with CRISPR-based genome editing of human stem cells for therapeutic use.

KW - CRISPR-Cas Systems/genetics

KW - Clustered Regularly Interspaced Short Palindromic Repeats/genetics

KW - Gene Editing

KW - Genetic Engineering

KW - Humans

KW - Organoids

UR - http://www.scopus.com/inward/record.url?scp=85094946103&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2020.10.014

DO - 10.1016/j.stem.2020.10.014

M3 - Review article

C2 - 33157047

SN - 1875-9777

VL - 27

SP - 705

EP - 731

JO - Cell stem cell

JF - Cell stem cell

IS - 5

ER -

CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit